Actavis is hoping to become the first to market generic versions of a contraceptive and a sedative, the drug maker said.
The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.
A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.
The U.S. healthcare system presents a paradox: It’s the most expensive system in the world, and yet it produces among the worst results among developed countries.
A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.
Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.
Drug maker Genzyme plans to present data from trial programs of two multiple sclerosis drugs at the American Academy of Neurology's annual meeting in New Orleans, which starts this Saturday and lasts until next Saturday.
A pharmacy benefit manager and the U.S. subsidiary of a German drug maker have made a deal concerning a drug for multiple sclerosis.
An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.
Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.
A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.
The Food and Drug Administration has approved a drug that it called the first single-pill combination treatment for Type 2 diabetes and high cholesterol.
German drug maker Merck KGaA will collaborate with Japanese drug maker Ono Pharmaceutical to develop oral therapies for cancer and multiple sclerosis, Merck KGaA said.
Merck KGaA announced that Robert Yates was named president of Merck Millipore, the drug maker's life science division.
German drug maker Merck KGaA said it finished enrolling patients in a late-stage clinical study of a drug for Parkinson's disease.
Merck KGaA division Merck Serono has appointed Belen Garijo as COO and Annalisa Jenkins as global head of drug development and medical, effective Sept. 5.
Merck will collaborate with a Korean manufacturer to develop a biosimilar version of a drug used for autoimmune diseases.
The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.
A Mylan subsidiary has settled a lawsuit brought on by the Department of Justice four years ago.
The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.
Data published in the latest issue of medical journal The Lancet showed that a recently...
German drug maker Merck KGaA has finished acquiring U.S. life-sciences company Millipore, Merck KGaA said...
A division of German drug maker Merck KGaA has resumed its clinical trial of a...
Swiss drug maker Biogen Idec and Irish drug maker Elan Corp. have started enrolling patients...
A mid-stage clinical trial program to investigate a Merck KGaA cancer vaccine has been put...